MARKET

NOTV

NOTV

Inotiv Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

22.50
+1.60
+7.66%
After Hours: 22.35 -0.15 -0.67% 16:21 04/16 EDT
OPEN
21.40
PREV CLOSE
20.90
HIGH
23.27
LOW
20.83
VOLUME
69.20K
TURNOVER
--
52 WEEK HIGH
23.27
52 WEEK LOW
3.800
MARKET CAP
250.45M
P/E (TTM)
-67.9348
1D
5D
1M
3M
1Y
5Y
Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.
WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of non-clinical and analytical contract research services, today announced that the Company has entered into an...
GlobeNewswire · 8h ago
Inotiv inks $47M deal for Bolder BioPATH
Inotiv (NOTV) has entered into an agreement and plan of merger with Bolder BioPATH, a contract pharmacology and pathology company.Bolder BioPATH specializes in in vivo models of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diseases of
Seekingalpha · 9h ago
BRIEF-Inotiv Inc Announces Expansion Of Pharmacology And Pathology Offerings With Agreement To Purchase Bolder Biopath Inc
reuters.com · 9h ago
Inotiv To Acquire Bolder BioPATH; Terms Not Disclosed
Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc. WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the
Benzinga · 9h ago
Inotiv Agrees to Purchase Bolder BioPATH for $47 Million
MT Newswires · 13h ago
Inotiv to buy all asset of HistoTox Labs for $22M
Inotiv (NOTV) announces that the company has entered into an agreement to purchase substantially all of the assets of HistoTox Labs, a full-service histopathology contract research organization offering medically relevant non-clinical
Seekingalpha · 3d ago
Inotiv, Inc. Agrees to Purchase HistoTox Labs, Inc.
Inotiv, Inc. Agrees to Purchase HistoTox Labs, Inc.
Dow Jones · 3d ago
Press Release: Inotiv, Inc. Enhances Histopathology Offering with Announcement of Agreement to Purchase HistoTox Labs, Inc.
Dow Jones · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NOTV. Analyze the recent business situations of Inotiv Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NOTV stock price target is 25.00 with a high estimate of 25.00 and a low estimate of 25.00.
EPS
Institutional Holdings
Institutions: 31
Institutional Holdings: 1.91M
% Owned: 17.20%
Shares Outstanding: 11.13M
TypeInstitutionsShares
Increased
1
100.05K
New
8
961.72K
Decreased
4
384.06K
Sold Out
4
12.47K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.60%
Pharmaceuticals & Medical Research
+0.89%
Key Executives
Chairman/Director
Gregory Davis
Chairman/Chief Executive Officer/Director
Paul Yonamine
President/Chief Executive Officer/Director
Robert Leasure
President/Director
Agnes Ngo
Chief Financial Officer/Vice President - Finance
Beth Taylor
Vice Chairman/Independent Director
Colbert Matsumoto
Chief Financial Officer/Executive Vice President/Treasurer
David Morimoto
Chief Operating Officer
Greg Beattie
Chief Operating Officer
John Beattie
Executive Vice President/Chief Marketing Officer
Kevin Dahlstrom
Chief Human Resource Officer
William Pitchford
Senior Vice President
Michael Baim
Executive Vice President
Blenn Fujimoto
Senior Vice President
Philip Downing
Executive Vice President
David Hudson
Executive Vice President
Arnold Martines
Vice President
Andrew Alexander
Other
Joe Flynn
Lead Director/Independent Director
Crystal Rose
Vice President
I.M. Grossi
Independent Director
Christine Camp
Vice President
Daniel Smeak
Other/Director
John Sagartz
Independent Director
Earl Fry
Independent Director
Wayne Kamitaki
Other
Adam Aulbach
Other
Joseph Flynn
Independent Director
Paul Kosasa
Independent Director
Richard Johnson
Independent Director
Duane Kurisu
Independent Director
R. Matthew Neff
Independent Director
Christopher Lutes
Independent Director
Wendy Perrow
Independent Director
Saedene Ota
No Data
About NOTV
Inotiv, Inc, formerly Bioanalytical systems, Inc., is an international contract research company providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers with scientific research and analytical instrumentation. The Company operates in two segments: research services and research products. The research services segment provides research and development support on a contract basis directly to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. The Company supports both the non-clinical and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, but also including biotherapeutics and devices.

Webull offers kinds of Inotiv Inc stock information, including NASDAQ:NOTV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NOTV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NOTV stock methods without spending real money on the virtual paper trading platform.